HDAC4 integrates PTH and sympathetic signaling in osteoblasts

Journal of Cell Biology

Volumn 205, Issue 6, 2014, Pages 771-780

  Obri, Arnaud ^a   Makinistoglu, Munevver Parla ^a   Zhang, Hong ^b   Karsenty, Gerard ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bone volume over tissue volume; BV TV; HDAC; Histone deacetylase; ISO; Isoproterenol; Parathyroid hormone; PTH; PTH related protein; PTHrP; Wild type; WT

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CATECHOLAMINE; HISTONE DEACETYLASE 4; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENOME; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; UBIQUITINATION;

ACTIVATING TRANSCRIPTION FACTOR 4; ANIMALS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; MEF2 TRANSCRIPTION FACTORS; MICE; MODELS, BIOLOGICAL; OSTEOBLASTS; PARATHYROID HORMONE; RANK LIGAND; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84903162356     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201403138     Document Type: Article

References (30)

1. Akhtar, M.W., M.S. Kim, M. Adachi, M.J. Morris, X. Qi, J.A. Richardson, R. Bassel-Duby, E.N. Olson, E.T. Kavalali, and L.M. Monteggia. 2012. In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. PLoS ONE. 7:e34863. http://dx.doi.org/10.1371/journal.pone .0034863
2. Allis, C.D., T. Jenuwein, D. Reinberg, and M.-L. Caparros, editors. 2007. Epigenetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 502 pp.
3. Arnold, M.A., Y. Kim, M.P. Czubryt, D. Phan, J. McAnally, X. Qi, J.M. Shelton, J.A. Richardson, R. Bassel-Duby, and E.N. Olson. 2007. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev. Cell. 12:377-389. http://dx.doi.org/10.1016/j.devcel.2007 .02.004
4. Backs, J., B.C. Worst, L.H. Lehmann, D.M. Patrick, Z. Jebessa, M.M. Kreusser, Q. Sun, L. Chen, C. Heft, H.A. Katus, and E.N. Olson. 2011. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J. Cell Biol.195:403-415. http://dx.doi.org/10.1083/jcb.201105063
5. Berger, S.L. 2002. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12:142-148. http://dx.doi.org/10.1016/S0959-437X(02)00279-4
6. Chang, S., T.A. McKinsey, C.L. Zhang, J.A. Richardson, J.A. Hill, and E.N. Olson. 2004. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell. Biol. 24:8467-8476. http://dx.doi.org/10.1128/MCB .24.19.8467-8476.2004
7. Cohen, T.J., D.S. Waddell, T. Barrientos, Z. Lu, G. Feng, G.A. Cox, S.C. Bodine, and T.P. Yao. 2007. The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J. Biol. Chem. 282:33752-33759. http://dx.doi.org/10.1074/jbc.M706268200
8. Ducy, P., and G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15:1858-1869.
9. Ducy, P., M. Starbuck, M. Priemel, J. Shen, G. Pinero, V. Geoffroy, M. Amling, and G. Karsenty. 1999. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 13:1025-1036. http://dx.doi.org/10.1101/gad.13.8.1025
10. Elefteriou, F., J.D. Ahn, S. Takeda, M. Starbuck, X. Yang, X. Liu, H. Kondo, W.G. Richards, T.W. Bannon, M. Noda, et al. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 434:514-520. http://dx.doi.org/10.1038/nature03398
11. Ferron, M., J. Wei, T. Yoshizawa, A. Del Fattore, R.A. DePinho, A. Teti, P. Ducy, and G. Karsenty. 2010. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell. 142:296-308. http://dx.doi.org/10.1016/j.cell.2010.06.003
12. Fu, Q., R.L. Jilka, S.C. Manolagas, and C.A. O'Brien. 2002. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response elementbinding protein. J. Biol. Chem. 277:48868-48875. http://dx.doi.org/10.1074/jbc.M208494200
13. Gao, Y., X. Wu, M. Terauchi, J.Y. Li, F. Grassi, S. Galley, X. Yang, M.N. Weitzmann, and R. Pacifici. 2008. T cells potentiate PTH-induced cortical bone loss through CD40L signaling. Cell Metab. 8:132-145. http://dx.doi.org/10 .1016/j.cmet.2008.07.001
14. Haberland, M., R.L. Montgomery, and E.N. Olson. 2009. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10:32-42. http://dx.doi.org/10.1038/nrg2485
15. Jenuwein, T., and C.D. Allis. 2001. Translating the histone code. Science. 293:1074-1080. http://dx.doi.org/10.1126/science.1063127
16. Kajimura, D., E. Hinoi, M. Ferron, A. Kode, K.J. Riley, B. Zhou, X.E. Guo, and G. Karsenty. 2011. Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual. J. Exp. Med. 208:841-851. http://dx.doi.org/10.1084/jem.20102608
17. Karsenty, G., and M. Ferron. 2012. The contribution of bone to whole-organism physiology. Nature. 481:314-320. http://dx.doi.org/10.1038/nature10763
18. Karsenty, G., H.M. Kronenberg, and C. Settembre. 2009. Genetic control of bone formation. Annu. Rev. Cell Dev. Biol. 25:629-648. http://dx.doi.org/10.1146/annurev.cellbio.042308.113308
19. Kondo, H., J. Guo, and F.R. Bringhurst. 2002. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J. Bone Miner. Res. 17:1667-1679. http://dx.doi.org/10.1359/jbmr .2002.17.9.1667
20. Kozhemyakina, E., T. Cohen, T.-P. Yao, and A.B. Lassar. 2009. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway. Mol. Cell. Biol.29:5751-5762. http://dx.doi.org/10.1128/MCB.00415-09
21. Kronenberg, H.M. 2003. Developmental regulation of the growth plate. Nature. 423:332-336. http://dx.doi.org/10.1038/nature01657
22. Potthoff, M.J., H. Wu, M.A. Arnold, J.M. Shelton, J. Backs, J. McAnally, J.A. Richardson, R. Bassel-Duby, and E.N. Olson. 2007. Histone deacetylase degradation and MEF2 activation promote the formation of slowtwitch myofibers. J. Clin. Invest. 117:2459-2467. http://dx.doi.org/10.1172/JCI31960
23. Rauch, A., S. Seitz, U. Baschant, A.F. Schilling, A. Illing, B. Stride, M. Kirilov, V. Mandic, A. Takacz, R. Schmidt-Ullrich, et al. 2010. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 11:517-531. http://dx.doi .org/10.1016/j.cmet.2010.05.005
24. Sévère, N., F.X. Dieudonné, and P.J. Marie. 2013. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis. Cell Death Dis. 4:e463. http://dx.doi.org/10.1038/cddis.2012.217
25. Tawfeek, H., B. Bedi, J.Y. Li, J. Adams, T. Kobayashi, M.N. Weitzmann, H.M. Kronenberg, and R. Pacifici. 2010. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss. PLoS ONE. 5:e12290. http://dx.doi.org/10.1371/journal.pone.0012290
26. Teitelbaum, S.L. 2000. Bone resorption by osteoclasts. Science. 289:1504-1508. http://dx.doi.org/10.1126/science.289.5484.1504
27. Vega, R.B., K. Matsuda, J. Oh, A.C. Barbosa, X. Yang, E. Meadows, J. McAnally, C. Pomajzl, J.M. Shelton, J.A. Richardson, et al. 2004. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell. 119:555-566. http://dx.doi.org/10.1016/j.cell.2004.10.024
28. Verdin, E., F. Dequiedt, and H.G. Kasler. 2003. Class II histone deacetylases:versatile regulators. Trends Genet. 19:286-293. http://dx.doi.org/10.1016/S0168-9525(03)00073-8
29. Yoshizawa, T., E. Hinoi, D.Y. Jung, D. Kajimura, M. Ferron, J. Seo, J.M. Graff, J.K. Kim, and G. Karsenty. 2009. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 119:2807-2817. http://dx.doi.org/10.1172/JCI39366
30. Zhang, C.L., T.A. McKinsey, S. Chang, C.L. Antos, J.A. Hill, and E.N. Olson. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell. 110:479-488. http://dx.doi.org/10.1016/S0092-8674(02)00861-9